{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000119","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.849171+00:00","generated_at":"2026-05-31T08:11:20.669586+00:00","sec_items":["3.03","5.02","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lifecore shareholders approve board declassification, share increase; appoints four new directors","bullets":["Shareholders approved phased-in board declassification: 21.6M for, 77K against.","Authorized common shares increased to 75M from 50M.","Four new directors appointed: Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, Matthew Korenberg.","Director Nathaniel Calloway resigned post-meeting; no disagreement cited.","2019 Stock Incentive Plan amended: +300K shares available, total 3,059,797 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000119","json":"https://secwatch.observer/filing/0001005286-24-000119.json","markdown":"https://secwatch.observer/filing/0001005286-24-000119.md","text":"https://secwatch.observer/filing/0001005286-24-000119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000119/0001005286-24-000119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000119/lndc-20240815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:11:20.669586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2d89695feb","claim":"Humberto C. Antunes was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000119/0001005286-24-000119-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"37329f9a75","claim":"Paul H. Johnson was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000119/0001005286-24-000119-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"569ea6b333","claim":"Matthew Korenberg was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000119/0001005286-24-000119-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b62a862780","claim":"Jason Aryeh was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000119/0001005286-24-000119-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}